Gemini 2.0

Benefit

+0.04

Harm

0.00

Net Good

0.04

Verified benefit

0.00

History

Cumulative score

Domains

Medicine & Health0.04

Release

Status released. First dated 19 Feb 2025.

Event timeline

Benefit19 Feb 2025

Gemini-based AI co-scientist proposes liver-fibrosis targets later tested in organoids

Google’s multi-agent AI co-scientist, built on Gemini 2.0, proposed epigenetic targets and drugs for liver fibrosis; Stanford collaborators reported anti-fibrotic activity of vorinostat and BRD4 inhibitors in human hepatic organoids.

Medicine & HealthprovisionalTier 2 Notable+0.04